Peripheral Neuropathies
Thallium neuropathy
Mar. 10, 2025
MedLink, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Worddefinition
At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas.
08.11.2025
Notice: News releases are not subject to review by MedLink Neurology’s Editorial Board.
Epilepsy affects over 70 million people worldwide, and a significant portion of patients suffer from drug-resistant epilepsy, where standard medications fail. Beyond the seizures themselves, many patients face a hidden but devastating burden: cognitive decline, including memory loss and difficulty concentrating. These symptoms are believed to stem from underlying inflammation and structural brain damage. The ketogenic diet has long been used to manage seizures in drug-resistant epilepsy, but its potential to protect brain function remains underexplored. Due to these challenges, researchers are turning their focus toward understanding how a ketogenic diet might preserve cognitive abilities by addressing the root causes of neurologic decline.
A research team at the Children's Hospital of Chongqing Medical University has published a study in Pediatric Discovery, revealing how the ketogenic diet can restore cognitive function following status epilepticus. The scientists used a well-established rat model to investigate changes in memory, behavior, brain structure, and inflammation. Central to their investigation was the NF-κB pathway—a master switch for inflammation in the brain—aiming to uncover whether the ketogenic diet’s protective effects are tied to suppression of this pathway and its downstream inflammatory responses.
In the study, juvenile rats were induced with SE using pilocarpine and then split into groups, with some receiving a ketogenic diet for either 7 or 20 days. The researchers conducted a series of behavioral tests, including the Morris water maze and Y-maze, to assess memory and spatial learning. Rats fed with a ketogenic diet demonstrated notable improvements in exploratory behavior and cognitive performance compared to their non-treated counterparts.
Microscopic analysis revealed that ketogenic diet-fed rats showed significantly less damage in the hippocampus—a brain region essential for memory. Neuronal density, myelin integrity, and axonal structure were all better preserved. This structural protection correlated with reduced levels of proinflammatory cytokines (IL-1beta, IL-6, TNF-alpha).
Molecular studies confirmed that a ketogenic diet suppressed activation of the NF-κB pathway, evident through decreased nuclear translocation of NF-κB p65 and reduced phosphorylation of IκB. These changes suggest that the ketogenic diet not only reduces inflammation but interrupts its signaling at the source. Together, the findings illustrate a two-pronged benefit: restoring memory and repairing brain damage—both mediated by curbing inflammation at the molecular level.
“Our research highlights a critical shift in how we view the ketogenic diet—not just as a seizure-control therapy, but as a powerful tool for brain repair,” said Dr. Xiaojie Song, corresponding author of the study. “By dialing down inflammation at the cellular level, ketogenic diet helps the brain recover from the long-term consequences of seizures. These results open up new possibilities for non-drug therapies that address both the seizures and the silent damage they leave behind. The future of epilepsy treatment may lie in the synergy of metabolic and molecular interventions.”
These findings offer exciting possibilities for expanding the role of the ketogenic diet in neurologic care. Beyond epilepsy, the ketogenic diet could emerge as a valuable intervention for other brain disorders marked by inflammation and cognitive decline, such as Alzheimer’s disease and traumatic brain injury. The ability to modulate the NF-κB pathway through dietary means opens a door to low-risk, non-invasive therapeutic strategies. Future research will need to explore how long these benefits last, the ideal duration of treatment, and whether combining the ketogenic diet with pharmacological agents could further amplify its effects—especially in vulnerable populations like children with drug-resistant epilepsy.
Source: News Release
Chinese Academy of Sciences
August 11, 2025
MedLink, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125